Laddar...

Neoadjuvant Immunotherapy: The Next Gold Standard Before Radical Surgery for Urothelial Cancer

Cisplatin-based chemotherapy followed by radical cystectomy with bilateral pelvic lymph-node dissection is the current standard for cT2–4a N0 M0 urothelial bladder cancer. Immune checkpoint inhibitors have recently been tested in the neoadjuvant setting with promising pathological and survival resul...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Eur Urol Open Sci
Huvudupphovsmän: Raggi, Daniele, Moschini, Marco, Necchi, Andrea
Materialtyp: Artigo
Språk:Inglês
Publicerad: Elsevier 2021
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8317828/
https://ncbi.nlm.nih.gov/pubmed/34337545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.euros.2021.06.001
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!